Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04938986 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Mar 2028 to Apr 2028
    • Start date changed from estimate of Mar 2022 to Apr 4, 2022
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary and study completion dates: Jul 2027 to Mar 2028
    • Start date: Jul 2021 to Mar 2022
    • Study sites: 0 to 2
    • Eligibility criteria revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Trial Details
NCT Number NCT04938986
Lead Sponsor Hospital St. Joseph, Marseille, France
Conditions
(from sponsor)		 Non Metastatic Colorectal Cancer
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov